Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 4,000 shares at $19.20 ($78K) on 2019-01-16, disclosed to the SEC on 2019-01-18.
Scheduled sale ($78k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.20 | 1,700 | $33K | 41.7% |
| 2 | $19.81 | 2,300 | $46K | 58.3% |
| Total | $19.55 avg | 4,000 | $78K | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |